Stephens Inc’s Compugen CGEN Stock Holding History

Stephens Inc’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,000	Closed	-$35.3K	–	1302
2024 Q2	$35.3K	Sell	21,000 -2,400	-10%	-$5K	﹤0.01%	1264
2024 Q1	$60.4K	Hold	23,400	–	–	﹤0.01%	1274
2023 Q4	$46.3K	Hold	23,400	–	–	﹤0.01%	1213
2023 Q3	$21.8K	Hold	23,400	–	–	﹤0.01%	1191
2023 Q2	$26.7K	Buy	23,400 +400	+2%	+$349	﹤0.01%	1206
2023 Q1	$16.1K	Hold	23,000	–	–	﹤0.01%	1174
2022 Q4	$16.5K	Hold	23,000	–	–	﹤0.01%	1151
2022 Q3	$15K	Hold	23,000	–	–	﹤0.01%	1187
2022 Q2	$43K	Hold	23,000	–	–	﹤0.01%	1167
2022 Q1	$74K	Hold	23,000	–	–	﹤0.01%	1242
2021 Q4	$99K	Hold	23,000	–	–	﹤0.01%	1259
2021 Q3	$137K	Hold	23,000	–	–	﹤0.01%	1251
2021 Q2	$190K	Hold	23,000	–	–	﹤0.01%	1215
2021 Q1	$198K	Buy	+23,000	New	+$255K	﹤0.01%	1171
2020 Q4	–	Sell	-23,000	Closed	-$374K	–	1227
2020 Q3	$374K	Hold	23,000	–	–	0.01%	812
2020 Q2	$345K	Hold	23,000	–	–	0.01%	800
2020 Q1	$167K	Buy	23,000 +7,000	+44%	+$55K	﹤0.01%	912
2019 Q4	$95K	Buy	+16,000	New	+$82.3K	﹤0.01%	1071

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Stephens Inc's CGEN Position: Q3 2024 in Review

Stephens Inc sold out of Compugen (CGEN) in Q3 2024, closing a stake of 21,000 shares — an estimated $35.3K sold.

Stephens Inc first reported a position in CGEN in Q4 2019 and held it in 18 quarters. The position peaked at $374K in Q3 2020. 65 funds tracked by Wall St. Rank hold CGEN as of Q3 2024.

Stephens Inc reported no remaining Compugen position as of Q3 2024 after selling out during the quarter.
Stephens Inc sold 21,000 Compugen shares in Q3 2024, an estimated $35.3K.
Stephens Inc first reported a position in Compugen in Q4 2019 and held it in 18 quarters.
Stephens Inc's Compugen position peaked at $374K in Q3 2020.
65 funds tracked by Wall St. Rank held Compugen as of Q3 2024.

Based on Stephens Inc's 13F filing for Q3 2024, filed 28 Oct 2024.